What does Field Medical do?
Field Medical is developing advanced pulsed field ablation (PFA) technology for the treatment of complex cardiac arrhythmias. The company's FieldForce Ablation System combines a novel catheter design with proprietary FieldBending energy to deliver rapid, targeted ablation.
How much did they raise?
The company raised $35M in a Series B round, co-led by BioStar Capital and Cue Growth, with participation from existing strategic investors.
What are their plans for the money?
Field Medical intends to use the funds to accelerate readiness for pivotal clinical trials and expand the ventricular tachycardia (VT) treatment market, potentially improving treatment options for patients with complex cardiac arrhythmias.
What have they achieved so far?
The company has advanced its proprietary technology with the FieldForce Ablation System and recently announced updates to its Board of Directors, highlighting its growth trajectory and commitment to innovation.
